The antibiotic drugs market was valued at USD 43.6 billion in 2022 and is expected to reach USD 64.9 billion by 2033. The market is set to record a growth of around 3.7% during the forecast period. The current antibiotic drugs market valuation is worth around USD 45.0 billion.
Increased generic medicine demand and rising healthcare spending are the key factors for market expansion. Bacterial infections are treated with erythromycin, amoxicillin, and ciprofloxacin. There are a wide variety of diverse antibiotics with different mechanisms of action, depending on the type of infection patients have. For instance, patients with severe parasite or bacterial illnesses typically receive antibiotic prescriptions.
Antibiotic medications can be categorized into various categories based on how they function. These include Penicillin, Fluoroquinolones, Cephalosporin, Macrolides, and others. Each has different effects depending upon the type and stage of infection. Increased regulatory approvals have led to marketing a greater variety of medications in the antibacterial treatment industry. Business experts are concentrating on getting government permits to sell products that adhere to regulations.
“The market is likely to benefit from rising investments by government and non-government organizations in research and development to make groundbreaking additions in medication and therapies to prevent infectious disease.” says an analyst of FMI.
Key Takeaways from the Market Study
- The penicillin segment held 27.9% of the overall antibiotic drugs market share in 2022 due to the increase in pneumonia and other respiratory tract diseases.
- Diarrhoea, vomiting, and other unpleasant symptoms are all brought on by gastrointestinal infections, due to which gastrointestinal diseases had a total market share of 26.0% in 2022.
- Due to the rising need for antibiotic medications to treat various infections, retail pharmacies had a 39.1% market share of the antibiotic drug market in 2022.
- North America accounts for the highest share of 23.9% of the antibiotic drugs share in 2022 due to the increased production and various research and development activities.
Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!
Market Competition
To diversify their product offerings and increase their geographical presence, leading industry participants in the antibiotic drugs market are concentrating on clinical trials and approval of innovative products.
- In October 2020, Pfizer added a new antibiotic candidate to its pipeline by acquiring Arixa. Through this acquisition, Pfizer aims to advance the program of ARX-1796, an oral beta-lactamase inhibitor with a combination of antibiotics.
- In August 2018, Xerava (eravacycline), a fluorocycline antibiotic of Tetraphase Pharmaceuticals indicated for treating complicated intra-abdominal infections, got its FDA approval.
Key Companies Profiled:
Abbott Laboratories; AbbVie; F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc; Merck & Co. Inc.; Mylan N.V.; Novartis International AG (Sandoz); Sanofi; Teva Pharmaceutical Industries Ltd.; Melinta Therapeutics; Pfizer Inc; Basilea Pharmaceutica Ltd.; Tetraphase Pharmaceuticals; Paratek Pharmaceuticals, Inc.; Nabriva Therapeutics plc; Spero Therapeutics
Antibiotic Drugs Market by Category:
By Drug class:
- Penicillins
- Fluoroquinolones
- Cephalosporins
- Macrolides
- Others
By Indication:
- Dermatological Infections
- Respiratory Infections
- Urinary Tract Infections
- Ear Infections
- Gastrointestinal Infections
- Others
By Route of Administration:
- Oral
- Parenteral
By Distribution Channel:
- Retail pharmacies
- Hospital pharmacies
- Online pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
